1Jeloka T,Mali M,Jhamnani A,et al.Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients[J] ? J Assoc Physicians India,2012,60(1):102-105.
2Sanchez CP.Adynamic bone revisited:is there progress[J] ?Perit DialInt,2006,26(1):43-48.
3Rhee H,Song SH,Kwak IS,Lee SB,et al.Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients[J] .Clin Exp Nephrol,2012,16(1):98-102.
4Frazo JM,Martins P.Adynamic bone disease:clinical and therapeutic implications[J] .Curr Opin Nephrol Hypertens,2009,18(4):303-307.
7Silverberg S,Gao p,Brown I,et al.Clinical utility of an immunoradiometric assay for parathyroid hormone(1-84) in primary hyperparathyroidism[J] .J Clin Endocrinol Metab,2003,88:4725-4730.
8Monier-Faugere M C,Geng Z,Mawad H,et al.Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients[J] .Kidney Int,2001,60:1460-1468.
9Kazama J J,Omori T,Ei I,et al.Circulating 1-84 PTH and large C-terminal fragment levels in uremia[J] .Clin Exp Nephrol,2003,7:144-149.
10CanterT,SciB.The assay of the hypocalcemic PTH fragment in hibitor with PTH provides a more accurate assessment of renalosteodystroply ocrnpared to the intact PTH assay[J] .Nefrologia,2003,23 (suppl):69-72.
2Gao P,Scheibel S,D'Amour P,et al.Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84:implications for improvement of accurate assessment of parathyroid function.J Bone Miner Res,2001,16:605-614.
3Silverberg S,Gao P,Brown I,et al.Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.J Clin Endocrinol Metab,2003,88:4725-4730.
4Silverberg A,Brown J,Bilezikian J,et al.A new highly sensitive assay for parathyroid hormone in primary hyperpara-thyroidism.J Bone Miner Res,2000,15 Suppl 1,S167.
5Qi Q,Faugere MC,Geng Z,et al.Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.Am J Kidney Dis,1995,26:622-631.
6Faugere MC,Gao P,Geng Z,et al.The 1-84:7-84 ratio for determination of bone turnover in chronically dialized patients.J Am Soc Nephrol,2000,11:554A.
7Tokumoto A.Superior assessment of bone turnover in ESRD patients by the 1-84 PTH/large C terminal PTH fragments ratioA bone biopsy study.J Am Soc Nephrol,2003,14:689A.
8Tokumoto A.Bone histology validation of the Scantibodies 1-84 PTH (CAP) assay and the 1-84 PTH/large C terminal PTH fragments ratio.J Am Soc Nephrol,2003,14:688A.
9D'Amour P,Rousseau L,Rocheleau B,et al.Influence of Ca^2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs.J Bone Miner Res,1996,11:1075-1085.
10Wang M,Hercz G,Sherrard DJ,et al.Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.Am J Kidney Dis,1995,26:836-844.
